At Core of Purdue Pharma Case: Who Can Get Immunity in Settlements?
New York Times
A broad ruling by the Supreme Court could mean the end of a strategy for resolving claims of mass injury in bankruptcy court in which organizations receive expansive legal protections.
https://www.nytimes.com/2023/12/03/us/politics/oxycontin-supreme-court-purdue-sacklers.html